Advertisement

The detection and significance of cerebrospinal fluid oligoclonal IgG

  • G. Giovannoni
  • E. J. Thompson

Abstract

Multiple sclerosis (MS) is characterised pathologically by inflammation, demyelination and variable degrees of axonal loss and gliosis. The inflammation tends to be perivascular and consists predominantly of macrophages, activated microglia, T and B lymphocytes, and occasional plasma cells. These plasma cells are responsible for the production of oligoclonal immunoglobulin (Ig) within the central nervous system (CNS), and the detection of this abnormal IgG in the cerebrospinal fluid (CSF) is useful as one of the laboratory criteria supporting the clinical diagnosis of MS.

Keywords

Multiple Sclerosis Oligoclonal Band Free Light Chain Definite Multiple Sclerosis Myelin Phagocytosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lowenthal A, van Sande M, Karcher D (1960) The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF γ-globulins. J Neurochem 6:51–5CrossRefGoogle Scholar
  2. 2.
    Andersson M, Alvarez-Cermeño J, Bernadi G et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897–902PubMedCrossRefGoogle Scholar
  3. 3.
    McLean BN, Luxton RW, Thompson EJ (1990) A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the log IgG-index. Brain 113:1269–1289PubMedCrossRefGoogle Scholar
  4. 4.
    Sharief MK, Thompson EJ (1991) The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for the subsequent development of multiple sclerosis. Ann Neurol 29:147–151PubMedCrossRefGoogle Scholar
  5. 5.
    Zeman AZJ, Kidd D, McLean BN et al (1996) A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60: 27–30PubMedCrossRefGoogle Scholar
  6. 6.
    Thompson EJ, Kaufmann P, Rudge P (1983) Sequential changes in oligoclonal patterns during the course of multiple sclerosis. J Neurol Neurosurg Psychiatry 46:115–118PubMedCrossRefGoogle Scholar
  7. 7.
    Lassmann H, Suchanek G, Ozawa K (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 36:S42–46PubMedCrossRefGoogle Scholar
  8. 8.
    Mattson DH, Roos RP, Arnason GW (1980) Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature 287:335–337PubMedCrossRefGoogle Scholar
  9. 9.
    Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. (1993) Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 14:203–207PubMedCrossRefGoogle Scholar
  10. 10.
    Wekerle H, Kojima K, Lannes-Vieira J, Lassman H, Linington C (1994) Animal models. Ann Neurol 36:S47–53PubMedCrossRefGoogle Scholar
  11. 11.
    Raine CS, Scheinberg LC (1988) On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 20:189–201PubMedCrossRefGoogle Scholar
  12. 12.
    Zeman AZJ, Keir G, Luxton R, Thompson EJ (1996) Serum oligoclonal bands are a common and persistent feature of multiple sclerosis and have a systemic origin. Q J Med 89:187–193Google Scholar
  13. 13.
    Vakaet A, Thompson EJ (1985) Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry 48:995–998PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • G. Giovannoni
    • 1
  • E. J. Thompson
    • 1
  1. 1.Department of NeuroimmunologyInstitute of NeurologyLondonUK

Personalised recommendations